Stay Updated with Annovis
(NYSE: ANVS)

Why Subscribe?

Get timely news on our clinical trials and research advancements.
Be the first to know about our webinars, conferences, and investor calls.
Stay informed with communication directly from our team.

About Annovis

Headquartered in Malvern, Pennsylvania, Annovis is dedicated to addressing neurodegeneration in diseases such as AD and PD. The company’s innovative approach targets multiple neurotoxic proteins, aiming to restore brain function and improve the quality of life for patients.

Join our Newsletters

Check - Elements Webflow Library - BRIX Templates

Thank you

Thanks for reaching out. We will get back to you soon.
Oops! Something went wrong while submitting the form.